| TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
| Immune System | R-HSA-168256 | 2.37 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.34 |
| RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.59 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Disease | R-HSA-1643685 | 3.33 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 10.18 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
| Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| NF-kB is activated and signals survival | R-HSA-209560 | 9.28 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.28 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
| TCR signaling | R-HSA-202403 | 6.64 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.4 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
| Downstream TCR signaling | R-HSA-202424 | 7.01 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.98 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.59 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
| Diseases of Immune System | R-HSA-5260271 | 8.34 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.98 |
| MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
| MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
| Activated TLR4 signalling | R-HSA-166054 | 6.27 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |